Followers | 149 |
Posts | 5036 |
Boards Moderated | 1 |
Alias Born | 04/14/2005 |
Wednesday, July 11, 2007 5:37:28 PM
New breast cancer treatment using balloon brachytherapy. Because the competition has used a uni-lumen approach only about 5% of the potential breast cancer candidates have been eligible for this procedure. What SenoRX (SENO) has developed with a multi-lumen approach, according to investigator radiation oncologists is that now 25% of the breast cancer patients will be eligible for treatment and a greatly expanded market of $75-$100 Million shall be created.
SenoRx is performing pre-launch activities for its balloon through 2007, in preparation for full commercial launch in 2008. The balloon is being introduced to select clinical sites where initial evaluation is being conducted prior to beginning further clinical and market testing studies.
FDA APPROVED!
Disclaimer: You are completely responsible for your own investment decisions and who and what you believe on the boards.You are responsible for properly analyzing and verifying any information you choose to rely upon.
Doc
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM